Datafoundry is listed in the industry report on ‘Artificial Intelligence in Drug Discovery’ by Deep Pharma Intelligence under the section ’10 Notable R&D Use Cases of AI Application in Biopharma’.
Find full report: https://www.deep-pharma.tech/ai-in-dd-q1-2023-subscribe
This report is the latest in a line of studies that DPI has been publishing on the issue of Artificial Intelligence (AI) applications in the pharmaceutical research sector since 2017.
Prediction of Adverse Drug Reactions has been an important aspect of Pharmacovigilance because of its impact in the pharma industry. The standard process of introduction of a new drug into a market involves a lot of clinical trials, tests, etc.
A Compendium of AI innovation stories
Healthcare & Lifesciences
DF mSafety AI: Automated & AI powered Safety Platform